Intrexon Corporation (XON) EPS Estimated At $-0.23

July 13, 2018 - By Mark Mitchell

Intrexon Corporation (NYSE:XON) LogoInvestors sentiment increased to 1.78 in 2018 Q1. Its up 0.40, from 1.38 in 2017Q4. It is positive, as 20 investors sold Intrexon Corporation shares while 26 reduced holdings. 24 funds opened positions while 58 raised stakes. 106.32 million shares or 10.20% more from 96.48 million shares in 2017Q4 were reported.
Tci Wealth Advisors invested 0.01% in Intrexon Corporation (NYSE:XON). Synovus Financial accumulated 22,188 shares. Pub Employees Retirement Sys Of Ohio invested in 0% or 22,060 shares. Macquarie Grp Inc accumulated 0% or 39,870 shares. Fmr Limited Co stated it has 0.01% in Intrexon Corporation (NYSE:XON). Raymond James Serv Advsrs has invested 0.01% in Intrexon Corporation (NYSE:XON). Third Security Limited has 65.66% invested in Intrexon Corporation (NYSE:XON). Lagoda Inv Management L P holds 176,702 shares or 1.02% of its portfolio. Earnest Ptnrs Lc holds 0% of its portfolio in Intrexon Corporation (NYSE:XON) for 11 shares. 124,584 were reported by Eagle Asset Management Inc. Principal Fincl Grp Incorporated accumulated 21,239 shares. Tocqueville Asset Mngmt Limited Partnership has invested 0% in Intrexon Corporation (NYSE:XON). Utah Retirement Sys reported 11,900 shares. Goldman Sachs Gp Incorporated accumulated 246,502 shares or 0% of the stock. Savings Bank Of Montreal Can reported 0% in Intrexon Corporation (NYSE:XON).

Since January 19, 2018, it had 2 insider purchases, and 0 insider sales for $112.50 million activity.

Analysts expect Intrexon Corporation (NYSE:XON) to report $-0.23 EPS on August, 8.They anticipate $0.07 EPS change or 43.75 % from last quarter’s $-0.16 EPS. After having $-0.17 EPS previously, Intrexon Corporation’s analysts see 35.29 % EPS growth. The stock increased 0.59% or $0.09 during the last trading session, reaching $15.38. About 807,000 shares traded. Intrexon Corporation (NYSE:XON) has declined 29.17% since July 14, 2017 and is downtrending. It has underperformed by 41.74% the S&P500.

Intrexon Corporation (NYSE:XON) Ratings Coverage

Among 3 analysts covering Intrexon (NYSE:XON), 1 have Buy rating, 0 Sell and 2 Hold. Therefore 33% are positive. Intrexon had 3 analyst reports since March 2, 2018 according to SRatingsIntel. The firm earned “Neutral” rating on Monday, March 5 by JP Morgan. The stock has “Buy” rating by Northland Capital on Friday, March 2. The stock has “Neutral” rating by Bank of America on Friday, March 2.

Intrexon Corporation operates in the synthetic biology field in the United States. The company has market cap of $2.01 billion. The company, through a suite of proprietary and complementary technologies, designs, builds, and regulates gene programs, which are DNA sequences that consist of key genetic components. It currently has negative earnings. The Company’s technologies include UltraVector gene design and fabrication platform, and its associated library of modular DNA components; Cell Systems Informatics; RheoSwitch inducible gene switch; AttSite Recombinases; Protein Engineering; Laser-Enabled Analysis and Processing; and ActoBiotics platform.

Intrexon Corporation (NYSE:XON) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.